Receptor-Interacting Protein Kinase 2 (RIPK2) and Nucleotide-Binding Oligomerization Domain (NOD) Cell Signaling Inhibitors Based on a 3,5-Diphenyl-2-aminopyridine Scaffold

Ítems similars

• Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling
  per: Hrdinka, Matous, et al.
  Publicat: (2018)
• Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling
  per: Nikhar, Sameer, et al.
  Publicat: (2021)
• Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
  per: Suebsuwong, Chalada, et al.
  Publicat: (2018)
• Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors
  per: Canning, Peter, et al.
  Publicat: (2015)
• Targeting RIPK1,2,3 to combat inflammation
  per: Bullock, Alex N., et al.
  Publicat: (2015)